Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Acorda Therapeutics, Inc. (ACOR) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Acorda Therapeutics, Inc. (ACOR) - free report >>
Image: Bigstock
New Strong Buy Stocks for March 30th
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
PLDT Inc. (PHI - Free Report) : This telecommunications company has seen the Zacks Consensus Estimate for its current year earnings increasing 10.6% over the last 60 days.
PLDT Inc. Price and Consensus
PLDT Inc. price-consensus-chart | PLDT Inc. Quote
Axcella Health Inc. (AXLA - Free Report) : This biotechnology companyhas seen the Zacks Consensus Estimate for its current year earnings increasing 16.9% over the last 60 days.
Axcella Health Inc. Price and Consensus
Axcella Health Inc. price-consensus-chart | Axcella Health Inc. Quote
Covenant Transportation Group, Inc. : This provider of transportation and logistics services has seen the Zacks Consensus Estimate for its current year earnings increasing 13.6% over the last 60 days.
Covenant Transportation Group, Inc. Price and Consensus
Covenant Transportation Group, Inc. price-consensus-chart | Covenant Transportation Group, Inc. Quote
Acorda Therapeutics, Inc. (ACOR - Free Report) : This developer of therapies for neurological disorders has seen the Zacks Consensus Estimate for its current year earnings increasing 8.9% over the last 60 days.
Acorda Therapeutics, Inc. Price and Consensus
Acorda Therapeutics, Inc. price-consensus-chart | Acorda Therapeutics, Inc. Quote
CyberOptics Corporation : This developer and manufacturer of high precision sensing technology solutions has seen the Zacks Consensus Estimate for its current year earnings increasing 3.9% over the last 60 days.
CyberOptics Corporation Price and Consensus
CyberOptics Corporation price-consensus-chart | CyberOptics Corporation Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here
The Hottest Tech Mega-Trend of All
Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>